NCT00641381
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +30 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,121 public trials
2,033 recruiting studies
Lymphoproliferative Disorders trial results
NCT04083534
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Regeneron Study Site Indianapolis, Indiana, United States
- Regeneron Study Site Ann Arbor, Michigan, United States
- Regeneron Study Site Rochester, Minnesota, United States
- Regeneron Study Site New York, United States
NCT01231412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
- Locations
-
- University of Colorado Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
NCT04819854
- Conditions
- Adult ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- The Medicines Evaluation Unit (MEU) Ltd. Manchester, United Kingdom
NCT03902184
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, Los Angeles (UCLA) - Medical Center Los Angeles, California, United States
- Irvine Medical Center Orange, California, United States
- Stanford University Stanford, California, United States
NCT06934109
- Conditions
- Communication Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +25 more
- Locations
-
- Nottinghamshire Healthcare NHS Foundation Trust Nottingham, United Kingdom
NCT05818423
- Conditions
- Cognition Disorders, Cognitive Decline, Cognitive Deficits, Mild, +16 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT02315612
- Conditions
- ALL, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +32 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Completed
Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors
NCT02211755
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04981795
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Alabama Oncology Birmingham, Alabama, United States
- Clearview Cancer Institute Huntsville, Alabama, United States
- University of California, Irvine Medical Center Orange, California, United States
- McFarland Clinic P.C. Ames, Iowa, United States